Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function

Background CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. Methods We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. Results Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. Conclusions Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41.

[1]  S. B. Moran,et al.  New insights on the role of sea ice in intercepting atmospheric pollutants using (129)I. , 2014, Marine pollution bulletin.

[2]  W. Greene,et al.  Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue , 2010, Cell.

[3]  P. D. de Bakker,et al.  Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. , 2011, The Journal of clinical investigation.

[4]  W. Greene,et al.  Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue , 2010, Cell.

[5]  P. Debré,et al.  HIV gp41 Engages gC1qR on CD4+ T Cells to Induce the Expression of an NK Ligand through the PIP3/H2O2 Pathway , 2010, PLoS pathogens.

[6]  A. Telenti,et al.  Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression , 2010, PloS one.

[7]  E. Bunnik,et al.  Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. , 2010, The Journal of infectious diseases.

[8]  C. Broder,et al.  Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly Neutralizing Serologic Activity , 2010, Journal of Virology.

[9]  A. Samri,et al.  Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers , 2010, Journal of acquired immune deficiency syndromes.

[10]  Richard T. Wyatt,et al.  Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables , 2009, Journal of Virology.

[11]  R. Siliciano,et al.  Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics , 2009, PLoS pathogens.

[12]  C. Apetrei,et al.  Lessons learned from the natural hosts of HIV-related viruses. , 2009, Annual review of medicine.

[13]  M. Piacentini,et al.  New insights on the role of apoptosis and autophagy in HIV pathogenesis , 2009, Apoptosis.

[14]  Todd M. Allen,et al.  Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  V. Robert-Hebmann,et al.  HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells , 2008, Autophagy.

[16]  J. Dausset,et al.  A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques , 2008, Proceedings of the National Academy of Sciences.

[17]  P. Debré,et al.  CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques , 2008, AIDS.

[18]  M. Churchill,et al.  Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS , 2007, Retrovirology.

[19]  Andrew J. Low,et al.  Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates , 2007, Antiviral therapy.

[20]  E. Freed,et al.  Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion* , 2007, Journal of Biological Chemistry.

[21]  H. Schuitemaker,et al.  Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic Disease , 2007, Journal of Virology.

[22]  P. Debré,et al.  Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection , 2006, AIDS.

[23]  Lynn Morris,et al.  A Reliable Phenotype Predictor for Human Immunodeficiency Virus Type 1 Subtype C Based on Envelope V3 Sequences , 2006, Journal of Virology.

[24]  J. Mascola,et al.  Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants , 2006, Journal of Virology.

[25]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[26]  P. Debré,et al.  NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Barretina,et al.  R5 HIV gp120‐mediated cellular contacts induce the death of single CCR5‐expressing CD4 T cells by a gp41‐dependent mechanism , 2004, Journal of leukocyte biology.

[28]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[29]  J. Barretina,et al.  Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. , 2003, Virology.

[30]  J. Barretina,et al.  CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro. , 2001, Virology.

[31]  J. Manola,et al.  Membrane-Fusing Capacity of the Human Immunodeficiency Virus Envelope Proteins Determines the Efficiency of CD4+ T-Cell Depletion in Macaques Infected by a Simian-Human Immunodeficiency Virus , 2001, Journal of Virology.

[32]  J. McCune,et al.  The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.

[33]  J. Sodroski,et al.  Importance of Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoproteins for Lysis of Primary CD4-Positive T Cells , 2000, Journal of Virology.

[34]  A. Badley,et al.  Mechanisms of HIV-associated lymphocyte apoptosis. , 2000, Blood.

[35]  J. Manola,et al.  The Envelope Glycoprotein Ectodomains Determine the Efficiency of CD4+ T Lymphocyte Depletion in Simian– Human Immunodeficiency Virus–Infected Macaques , 1998, The Journal of experimental medicine.

[36]  D. Baltimore,et al.  HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism , 1998, The Journal of experimental medicine.

[37]  J. Mallol,et al.  Characterization of adenosine receptors in brush‐border membranes from pig kidney , 1992, British journal of pharmacology.

[38]  E. Freed,et al.  Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Goudsmit,et al.  ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY , 1989, The Lancet.

[40]  M. Malim,et al.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes , 1988, Nature.